Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Pleyris versus Prometrium for endometrial protection in postmenopausal women on hormone replacement therapy
2014-001185-10Phase 2Terminated
- Sponsor
- IBSA Group
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of Luteon and progesterone in menopause (3 arms), sponsored by IBSA Group. Primary endpoint: Change in endometrial thickness. Started Jul 2014; status: terminated.
02
Drugs
Luteonprogesterone
03
Conditions
menopause
Beyond the preview
Go deeper on 2014-001185-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001185-10.